Cargando…

Cancer‐associated thrombosis: Role of direct oral anticoagulants

Detalles Bibliográficos
Autores principales:	Ikeda, Masataka, Matsuda, Chu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236109/ https://www.ncbi.nlm.nih.gov/pubmed/30460350 http://dx.doi.org/10.1002/ags3.12204

Ejemplares similares

The Role of Direct Oral Anticoagulants in Treatment of Cancer-Associated Thrombosis
por: Al-Samkari, Hanny, et al.
Publicado: (2018)

The Role of Direct Oral Anticoagulants in Cancer-Associated Thrombosis According to the Current Literature
por: Nana, Petroula, et al.
Publicado: (2021)

Direct Oral Anticoagulants for the Prevention and Acute Treatment of Cancer-Associated Thrombosis
por: Attard, Laura M, et al.
Publicado: (2022)

The role of direct oral anticoagulants in venous thromboembolic disease in gynecologic cancer
por: Park, Jeong-Yeol
Publicado: (2019)

Direct Oral Anticoagulants and Cancer Thrombosis: What APs Need to Know
por: Wilks, Mailey L.
Publicado: (2022)

Thrombosis and anticoagulation in COVID-19
por: Ramos, Roberta Pulcheri, et al.
Publicado: (2020)

Postoperative Ovarian Vein Thrombosis and Treatment with Direct Oral Anticoagulant
por: Shukr, Ghadear, et al.
Publicado: (2023)

Direct Oral Anticoagulants and Cancer-Associated Thrombosis Management. Where Do We Stand in 2019?
por: Ramacciotti, Eduardo, et al.
Publicado: (2019)

Anticoagulation in difficult settings RELOADed: Evidence for applicability of direct oral anticoagulants in patients with atrial fibrillation, renal impairment and cancer
por: Fender, Anke C., et al.
Publicado: (2019)

Functional lupus anticoagulant testing in a large retrospective cohort of thrombosis patients with direct oral anticoagulants
por: Reda, Sara, et al.
Publicado: (2020)

Direct Oral Anti-Coagulants Continue to Bud into Gynecological Cancer-Thrombosis Prevention
por: Tafur, Alfonso J., et al.
Publicado: (2022)

Direct oral anticoagulation and severe obesity – One size fits all?
por: Fender, Anke C., et al.
Publicado: (2021)

Direct Oral Anticoagulants (DOAC): Are We Ready for a Pharmacogenetic Approach?
por: Palmirotta, Raffaele
Publicado: (2021)

Direct oral anticoagulants for treatment of deep vein thrombosis: overview of systematic reviews
por: Brandão, Gustavo Muçouçah Sampaio, et al.
Publicado: (2018)

Treatment with direct oral anticoagulants in patients with upper extremity deep vein thrombosis
por: Montiel, Francisco Sánchez, et al.
Publicado: (2017)

Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review
por: Bose, Gauruv, et al.
Publicado: (2021)

Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis
por: Chun, Ho Soo, et al.
Publicado: (2021)

Direct oral anticoagulants for the treatment of splanchnic vein thrombosis: A state of art
por: Monaco, Giovanni, et al.
Publicado: (2023)

Direct Oral Anticoagulant Therapy for Isolated Distal Deep Vein Thrombosis Associated with Cancer in Routine Clinical Practice
por: Ogino, Yutaka, et al.
Publicado: (2021)

Target-Specific Oral Anticoagulants—New Approaches in the Field of Oral Anticoagulation
por: Mani, Helen, et al.
Publicado: (2015)

Factors associated with prescription of oral anticoagulants in the era of direct oral anticoagulants
por: Kataoka, Naoya, et al.
Publicado: (2023)

Venous thrombosis recurrence risk according to warfarin versus direct oral anticoagulants for the secondary prevention of venous thrombosis
por: Zakai, Neil A., et al.
Publicado: (2021)

Is Left Atrial Appendage Occlusion Always Better than Direct Oral Anticoagulants?
por: Kim, Jun
Publicado: (2021)

Recent Management Option for Hemorrhagic Stroke during Direct Oral Anticoagulant Therapy
por: Fujimura, Miki
Publicado: (2023)

Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review protocol
por: Bose, Gauruv, et al.
Publicado: (2019)

Thrombosis in myeloproliferative neoplasms: Treatment outcomes of direct oral anticoagulants and vitamin K antagonists
por: Fedorov, Kateryna, et al.
Publicado: (2021)

Direct oral anticoagulant administration in cirrhotic patients with portal vein thrombosis: What is the evidence?
por: Biolato, Marco, et al.
Publicado: (2022)

Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism
por: Masini, Marta, et al.
Publicado: (2023)

Oral Anticoagulants for Atrial Fibrillation Patients with Active Cancer
por: Kim, Do Young, et al.
Publicado: (2018)

Efficacy and safety of direct oral anticoagulants for secondary prevention of cancer associated thrombosis: a meta-analysis of randomized controlled trials
por: Desai, Ruchi, et al.
Publicado: (2020)

Direct oral anticoagulants versus low molecular weight heparins for the treatment of cancer-associated thrombosis: a cost-effectiveness analysis
por: Wumaier, Kaidireyahan, et al.
Publicado: (2021)

Direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism
por: Yhim, Ho-Young, et al.
Publicado: (2014)

Comparing intracerebral hemorrhages associated with direct oral anticoagulants or warfarin
por: Kurogi, Ryota, et al.
Publicado: (2018)

In Search of Safe and Effective Oral Anticoagulation
por: Curtiss, Frederic R.
Publicado: (2005)

Recent Advances in Anticoagulant Treatment of Immune Thrombosis: A Focus on Direct Oral Anticoagulants in Heparin-Induced Thrombocytopenia and Anti-Phospholipid Syndrome
por: Carré, Julie, et al.
Publicado: (2021)

New horizons in anticoagulation: Direct oral anticoagulants and their implications in oral surgery
por: Serrano-Sánchez, Víctor, et al.
Publicado: (2017)

Use of New Oral Anticoagulants / Direct Oral Anticoagulants in Malignant Patients
por: Khan, Yusra, et al.
Publicado: (2020)

Reversal of direct oral anticoagulants
por: Almegren, Mosaad
Publicado: (2017)

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants
por: Favaloro, Emmanuel J., et al.
Publicado: (2022)

Can We Improve on the Rapid Assessment of Clinically Relevant Levels of Direct Acting Oral Anticoagulants (DOAC)?
por: Walenga, Jeanine M.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1tqrq280t3pkj470vaf13s6lb5